Search - tctmd.com

Displaying 261 - 280 of 1006

Sort: Relevancy | Date

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

Presenter: Pieter Smits

October 29, 2024

Presentation TCT 2024

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Usman Akbar

October 29, 2024

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

Presenter: Ricky E Lemus-Zamora

October 29, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

Case: Rising Gradients Soon After TAVR

Presenter: Mahesh Madhavan

October 28, 2024

Presentation TCT 2024

Comparative Data of Valve Performance Between Latest Generation Intra-Annular Versus Supra-Annular Self-Expandable Transcatheter Heart Valves in Small Aortic Annuli

Presenter: Masahiko Asami

October 28, 2024

Presentation TCT 2024

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

Presenter: Ron Waksman

October 28, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Presenter: Amit Vora

October 28, 2024

Presentation TCT 2024

Case: New LBBB After TAVR

Presenter: Jason Bloom

October 28, 2024

Presentation TCT 2024

Post-TAVR Risk-Stratification for Conduction Disturbances

Presenter: Shmuel Chen

October 28, 2024

Presentation TCT 2024

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

Presenter: Jaroslaw Trebacz

October 28, 2024

Presentation TCT 2024

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

Presenter: Amar Krishnaswamy

October 28, 2024

Presentation TCT 2024

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

Presenter: Pradeep Yadav

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation TCT 2024

TCT 1120: Percutaneous Rescue of Iatrogenic Aortic Coarctation After Endoprosthesis Surgical Implantation

Presenter: luis Fernandez Gonzalez

October 28, 2024

Presentation TCT 2024

The Foldax Polymeric Leaflet TAVR Systems

Presenter: Steven Yakubov

October 28, 2024

Advertisement

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

TCT 129: Short and Long-term Outcomes Associated With New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

TCT 97: A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

Case: Rising Gradients Soon After TAVR

Comparative Data of Valve Performance Between Latest Generation Intra-Annular Versus Supra-Annular Self-Expandable Transcatheter Heart Valves in Small Aortic Annuli

Two-Year Outcomes in the Navitor IDE Study Utilizing an Intra-Annular, Self-Expandable Transcatheter Aortic Heart Valve

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Incidence, Relevance, and Prevention of New-onset LBBB and PPM Implantation After TAVR

Case: New LBBB After TAVR

Post-TAVR Risk-Stratification for Conduction Disturbances

The Optimum Short Frame Self-Expanding TAVR System (Optimum TAV)

The DurAVR System with Biomimetic Leaflet Design: Impact on Flow Dynamics and LV Mass Regression

The Ballon Expandable Siegel TAVR System: A Low-Profile Molybdenum-Rhenium Alloy Frame Design (MIRus)

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

The EARLY TAVR Trial Editorial Commentary

TCT 1120: Percutaneous Rescue of Iatrogenic Aortic Coarctation After Endoprosthesis Surgical Implantation

The Foldax Polymeric Leaflet TAVR Systems

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content